Fifth Third Bancorp Bio Techne Corp Transaction History

Fifth Third Bancorp

$27.3 Billion
Q3 2024

A detailed history of Fifth Third Bancorp transactions in Bio Techne Corp stock. As of the latest transaction made, Fifth Third Bancorp holds 8,205 shares of TECH stock, worth $582,965. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,205

Previous 7,894 3.94%

Holding current value

$582,965

Previous $565,000 15.93%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	BUY	$70.96 - $82.35 $22,068 - $25,610	311 Added 3.94%	8,205 $655,000
Q2 2024 Jul 22, 2024	BUY	$62.12 - $84.15 $68,456 - $92,733	1,102 Added 16.22%	7,894 $565,000
Q1 2024 Apr 23, 2024	BUY	$65.98 - $77.09 $58,326 - $68,147	884 Added 14.96%	6,792 $478,000
Q4 2023 Jan 19, 2024	BUY	$52.83 - $78.22 $125,418 - $185,694	2,374 Added 67.18%	5,908 $455,000
Q3 2023 Oct 31, 2023	SELL	$67.52 - $89.42 $44,293 - $58,659	-656 Reduced 15.66%	3,534 $240,000
Q2 2023 Jul 25, 2023	BUY	$73.76 - $85.98 $88,659 - $103,347	1,202 Added 40.23%	4,190 $342,000
Q1 2023 Apr 24, 2023	BUY	$71.62 - $86.62 $47,484 - $57,429	663 Added 28.52%	2,988 $221,000
Q4 2022 Jan 25, 2023	BUY	$80.67 - $352.29 $159,807 - $697,886	1,981 Added 575.87%	2,325 $0
Q3 2022 Oct 25, 2022	SELL	$282.54 - $391.85 $59,615 - $82,680	-211 Reduced 38.02%	344 $98,000
Q2 2022 Aug 04, 2022	BUY	$322.67 - $449.65 $55,821 - $77,789	173 Added 45.29%	555 $192,000
Q1 2022 Apr 19, 2022	BUY	$353.85 - $487.79 $64,046 - $88,289	181 Added 90.05%	382 $165,000
Q4 2021 Feb 01, 2022	BUY	$456.15 - $525.06 $22,807 - $26,252	50 Added 33.11%	201 $104,000
Q3 2021 Oct 15, 2021	BUY	$444.87 - $538.88 $33,810 - $40,954	76 Added 101.33%	151 $73,000
Q2 2021 Aug 06, 2021	BUY	$387.35 - $450.26 $5,422 - $6,303	14 Added 22.95%	75 $34,000
Q1 2021 May 07, 2021	SELL	$314.62 - $411.0 $180,277 - $235,503	-573 Reduced 90.38%	61 $23,000
Q4 2020 Feb 16, 2021	BUY	$246.9 - $321.87 $26,171 - $34,118	106 Added 20.08%	634 $201,000
Q3 2020 Nov 09, 2020	SELL	$232.22 - $282.96 $5,573 - $6,791	-24 Reduced 4.35%	528 $131,000
Q2 2020 Aug 05, 2020	SELL	$185.43 - $279.56 $29,854 - $45,009	-161 Reduced 22.58%	552 $146,000
Q1 2020 May 05, 2020	SELL	$161.17 - $221.51 $10,959 - $15,062	-68 Reduced 8.71%	713 $135,000
Q4 2019 Feb 14, 2020	BUY	$189.68 - $222.09 $27,882 - $32,647	147 Added 23.19%	781 $171,000
Q3 2019 Nov 14, 2019	SELL	$183.56 - $216.72 $2,936 - $3,467	-16 Reduced 2.46%	634 $124,000
Q2 2019 Aug 07, 2019	SELL	$188.72 - $215.43 $28,308 - $32,314	-150 Reduced 18.75%	650 $136,000
Q1 2019 May 14, 2019	BUY	$136.09 - $200.44 $3,810 - $5,612	28 Added 3.63%	800 $159,000
Q3 2018 Nov 14, 2018	SELL	$147.44 - $204.11 $3,980 - $5,510	-27 Reduced 3.38%	772 $158,000
Q2 2018 Aug 14, 2018	SELL	$144.9 - $165.58 $1,738 - $1,986	-12 Reduced 1.48%	799 $118,000
Q1 2018 May 15, 2018	BUY	$131.46 - $151.04 $23,794 - $27,338	181 Added 28.73%	811 $122,000
Q4 2017 Feb 14, 2018	BUY	$121.17 - $134.75 $12,601 - $14,014	104 Added 19.77%	630 $82,000
Q3 2017 Nov 14, 2017	SELL	$113.59 - $123.78 $3,521 - $3,837	-31 Reduced 5.57%	526 $64,000
Q2 2017 Aug 11, 2017	BUY	N/A	557	557 $65,000

Others Institutions Holding TECH

# of Institutions

601

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.79B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.

Account

Fifth Third Bancorp Bio Techne Corp Transaction History